NEW YORK (GenomeWeb News) – Genetic Technologies' fiscal 2013 first-quarter revenues dropped 50 percent year over year, the Australian firm said today in a regulatory document.

For the three months ended Sept. 30, GTG posted A$1.2 million (US$1.2 million) in receipts, down from A$2.4 million a year ago. Its loss for the quarter rose 69 percent to A$2.2 million from A$1.3 million a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.